This product is a mouse monoclonal antibody that is specific for EBV EBNA1. This antibody can be used in a variety of applications, such as ELISA, WB, IF.
Figure 1 IgG antibody to EBNA‐1 cross‐reacts with dsDNA.
IgG MAb, 3D4 binds strongly to EBNA-1 (A) and cross-reacts with dsDNA (B) as determined by ELISA. ELISAs are representative of three experiments.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 2 16D2 was tested by ELISA for binding to EBNA‐1.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 3 16D2 was tested by ELISA for binding to dsDNA.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 4 Binding to dsDNA was confirmed by immunostaining of the kinetoplast of Crithidia luciliae (C). Immunostaining of an isotype control MAb is shown in D (D).
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 5 16D2 was tested by ELISA for reactivity with a panel of antigens; Sm, LPS, BSA, and proteinase 3 (PR3).
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 6 16D2 binds to an epitope in the carboxyl region of EBNA‐1.
(A) Open reading frame map of EBNA-1 showing the amino (LS8) and carboxyl (LS9) region. (B) 16D2 was tested by ELISA for binding to LS8 and LS9 and shown to bind LS9 only. (C) Schematic of three truncated recombinant fragments of LS9 expressed in and purified from E. coli. (D) 16D2 was tested by ELISA for binding to the truncated fragments, aa 452-641, aa 459-619, and aa 459-607 and compared to the binding to LS9 (aa 410-641).
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 7 Comparison of the binding of 3D4 and 16D2 to EBNA‐1.
The binding of 16D2 and 3D4 to EBNA-1were compared by ELISA. Goat anti-mouse kappa-AP was used as secondary antibody to detect the binding of 16D2 (an IgM MAb) and 3D4 (an IgG MAb) in the same assay.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 8 Peptide mapping.
16D2 was tested by ELISA for binding to peptides spanning the entire 148 amino acid VBS region. Insets compare binding of 16D2 to EBNA-1 and PFM-15.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 9 Peptide mapping.
(C) Comparison of amino acid sequence of homologous peptides GC-15, PFM-15, and GL-15. Common core region of all three peptides is underlined. Regions of overlap between GC-15 and PFM-15 and between PFM-15 and GL-15 are bolded. 3D4 (D) and 16D2 (E) were examined by ELISA for binding to GC-15, GL-15, and PFM-15. 3D4 was used at a concentration of 5 μg/ml and 16D2 at 10 μg/ml for all above ELISAs.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 10 Peptide inhibition of MAbs binding to EBNA‐1.
16D2 (5 μg/ml) was incubated with increasing concentrations of peptides PFM-15 or GC-15 and examined by ELISA for binding to EBNA-1.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
Figure 11 Peptide inhibition of MAbs binding to dsDNA.
16D2 (5 μg/ml) was incubated with increasing concentrations of peptides PFM-15 or GC-15 and examined by ELISA for binding dsDNA.
Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MHC-YF066 | DRB1*01:01/EBV EBNA1 (TSLYNLRRGTALA) MHC Monomer | MHC Multimer | |
MHC-YF068 | DRB1*04:01/EBV EBNA1 (AEGLRALLARSHVER) MHC Monomer | MHC Multimer | |
MHC-YF072 | DRB1*07:01/EBV EBNA1 (VYGGSKTSLYNLRRGTALAI) MHC Monomer | MHC Multimer | |
MHC-YF073 | DRB1*07:01/EBV EBNA1 (PGPLRESIVCYFMVFLQTHI) MHC Monomer | MHC Multimer | |
MHC-YF177 | B*35:01/EBV EBNA1 (HPVGEADYFEY) MHC Monomer | MHC Multimer |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0523WJ | Mouse Anti-EBNA-1 Recombinant Antibody (clone 3D4) | ELISA, WB, IF | Mouse IgG, κ |
There are currently no Customer reviews or questions for FAMAB-0524WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.